The Beauty Health Company Class A Common Stock earnings per share and revenue
On Nov 06, 2025, SKIN reported earnings of -0.09 USD per share (EPS) for Q3 25, missing the estimate of -0.06 USD, resulting in a -30.25% surprise. Revenue reached 70.66 million, compared to an expected 69.96 million, with a 0.99% difference. The market reacted with a +8.53% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 10 analysts forecast an EPS of -0.04 USD, with revenue projected to reach 79.34 million USD, implying an decrease of -55.56% EPS, and increase of 12.29% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Danaher Corporation
Report Date
Jan 28, 2026 For Q4 25
Estimate
$2.17
Actual
$2.23
Surprise
+2.56%
HCA Healthcare, Inc.
Report Date
Jan 27, 2026 For Q4 25
Estimate
$7.53
Actual
$8.14
Surprise
+8.05%
Elevance Health, Inc.
Report Date
Jan 28, 2026 For Q4 25
Estimate
$3.12
Actual
$3.33
Surprise
+6.46%
FAQ
What were The Beauty Health Company Class A Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, The Beauty Health Company Class A Common Stock reported EPS of -$0.09, missing estimates by -30.25%, and revenue of $70.66M, 0.99% above expectations.
How did the market react to The Beauty Health Company Class A Common Stock's Q3 2025 earnings?
The stock price moved up 8.53%, changed from $1.29 before the earnings release to $1.40 the day after.
When is The Beauty Health Company Class A Common Stock expected to report next?
The next earning report is scheduled for Mar 10, 2026.
What are the forecasts for The Beauty Health Company Class A Common Stock's next earnings report?
Based on 10
analysts, The Beauty Health Company Class A Common Stock is expected to report EPS of -$0.04 and revenue of $79.34M for Q4 2025.